Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: In vivo and in vitro studies

Toxicon

Volumn 49, Issue 1, 2007, Pages 57-67

  Isbister, Geoffrey K ^a,b   O'Leary, Margaret A ^b   Schneider, Jennifer J ^c   Brown, Simon G A ^d   Currie, Bart J ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d FREMANTLE HOSPITAL   (Australia)

Author keywords

Antivenom; Brown snake; Coagulopathy; Procoagulant; Pseudonaja sp.; Snake envenoming

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CHROMOGENIC SUBSTRATE; PROCOAGULANT; PROTHROMBIN; SNAKE VENOM; SNAKE VENOM ANTISERUM; THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; ENVENOMATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; PLASMA; PRIORITY JOURNAL; SNAKE; THROMBIN TIME; VENOM INDUCED CONSUMPTION COAGULOPATHY;

ANIMALS; ANTIVENINS; AUSTRALIA; BLOOD COAGULATION; ELAPID VENOMS; ELAPIDAE; HUMANS; PROTHROMBIN; SNAKE BITES;

PSEUDONAJA; STORERIA DEKAYI;

EID: 33845390337     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2006.09.007     Document Type: Article

References (29)

1. Birrell G.W., Earl S., Masci P.P., de Jersey J., Wallis T.P., Gorman J.J., and Lavin M.F. Molecular diversity in venom from the Australian Brown snake, Pseudonaja textilis. Mol. Cell Proteomics 5 (2006) 379-389
2. Coulter A.R., Harris R.D., and Sutherland S.K. Clinical laboratory: enzyme immunoassay for the rapid clinical identification of snake venom. Med. J. Aust. 1 (1980) 433-435
3. Crowther, J.R., 1995. ELISA: theory and practice. In: Totowa, N.J. (Ed.), Methods in molecular biology, Vol. 42. Humana Press.
4. Currie B.J. Snakebite in tropical Australia, Papua New Guinea and Irian Jaya. Emerg. Med. 12 (2000) 285-294
5. Currie B.J. Snakebite in Australia: the role of the Venom Detection Kit. Emerg. Med. Australas. 16 (2004) 384-386
6. Currie B.J. Snakebite in tropical Australia: a prospective study in the "Top End" of the Northern Territory. Med. J. Aust. 181 (2004) 693-697
7. Dart R.C., and McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann. Emerg. Med. 37 (2001) 181-188
8. Filippovich I., Sorokina N., St Pierre L., Flight S., de Jersey J., Perry N., Masci P.P., and Lavin M.F. Cloning and functional expression of venom prothrombin activator protease from Pseudonaja textilis with whole blood procoagulant activity. Br. J. Haematol. 131 (2005) 237-246
9. Gutierrez J.M., Leon G., and Lomonte B. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin. Pharmacokinet. 42 (2003) 721-741
10. Ho M., Silamut K., White N.J., Karbwang J., Looareesuwan S., Phillips R.E., and Warrell D.A. Pharmacokinetics of three commercial antivenoms in patients envenomed by the Malayan pit viper, Calloselasma rhodostoma, in Thailand. Am. J. Trop. Med. Hyg. 42 (1990) 260-266
11. Isbister G.K. Antivenom, anecdotes and evidence. Med. J. Aust. 181 (2004) 685-686
12. Isbister G.K., Currie B.J., Little M., Daly F.F., and Isbister J.P. Coagulopathy from tiger snake envenoming and its treatment. Pathology 34 (2002) 588-590
13. Jelinek G.A., Smith A., Lynch D., Celenza A., Irving I., Michalopoulos N., Erber W., and Joske D.J. The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom-treated brown snake envenoming. Anaesth. Intens. Care 33 (2005) 36-40
14. Madaras F., Mirtschin P.J., and Kuchel T. Antivenom development in Australia. Toxin Rev. 24 (2005) 79-94
15. Marsh N. Inventory of haemorrhagic factors from snake venoms. Registry of Exogenous Hemostatic Factors. Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Thromb. Haemost. 71 (1994) 793-797
16. Masci P.P., Whitaker A.N., and de Jersey J. Purification and characterization of a prothrombin activator from the venom of the Australian brown snake, Pseudonaja textilis textilis. Biochem. Int. 17 (1988) 825-835
17. Milani J.R., Jorge M.T., de Campos F.P., Martins F.P., Bousso A., Cardoso J.L., Ribeiro L.A., Fan H.W., Franca F.O., Sano-Martins I.S., Cardos D., Ide, Fernandez C., Fernandes J.C., Aldred V.L., Sandoval M.P., Puorto G., Theakston R.D., and Warrell D.A. Snake bites by the jararacucu (Bothrops jararacussu): clinicopathological studies of 29 proven cases in Sao Paulo State, Brazil. QJM 90 (1997) 323-334
18. O'Leary M.A., Isbister G.K., Schneider J.J., Brown S.G.A., and Currie B.J. Enzyme Immunoassays in Brown Snake (Pseudonaja spp.) envenoming: detecting venom, antivenom and venom-antivenom complexes. Toxicon 48 1 (2006) 4-11
19. Pearn J., Morrison J., Charles N., and Muir V. First-aid for snake-bite: efficacy of a constrictive bandage with limb immobilization in the management of human envenomation. Med. J. Aust. 2 (1981) 293-295
20. Reid H.A. Prolonged defibrination syndrome after bite by the carpet viper Echis carinatus. BMJ 2 (1977) 1326
21. Sprivulis P., Jelinek G.A., and Marshall L. Efficacy and potency of antivenoms in neutralizing the procoagulant effects of Australian snake venoms in dog and human plasma. Anaesth Intens Care 24 (1996) 379-381
22. Sutherland S.K., and Leonard R.L. Snakebite deaths in Australia 1992-1994 and a management update. Med. J. Aust. 163 (1995) 616-618
23. Tibballs J., and Sutherland S. The efficacy of antivenom in prevention of cardiovascular depression and coagulopathy induced by brown snake (Pseudonaja) species venom. Anaesth Intens Care 19 (1991) 530-534
24. Warrell D.A., and Arnett C. The importance of bites by the saw-scaled or carpet viper (Echis carinatus): epidemiological studies in Nigeria and a review of the world literature. Acta Tropica 33 (1976) 307-341
25. White J. Why do people still die from brown-snake bites?. Emerg. Med. 12 (2000) 204-206
26. White J. CSL Antivenom Handbook (2001), CSL Ltd, Melbourne
27. White J., Warrell D., Eddleston M., Currie B.J., Whyte I.M., and Isbister G.K. Clinical toxinology-where are we now?. J. Toxicol. Clin. Toxicol. 41 (2003) 263-276
28. Williams V., White J., and Mirtschin P.J. Comparative study on the procoagulant from the venom of Australian brown snakes (Elapidae; Pseudonaja spp.). Toxicon 32 (1994) 453-459
29. Yeung J.M., Little M., Murray L.M., Jelinek G.A., and Daly F.F. Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Western Australia over 10 years. Med. J. Aust. 181 (2004) 703-705